We warmly welcome you to the 11th International Symposium on Minimal Residual Cancer in Montpellier in the south of France.
These international ISMRC meetings started in 1996 and have established themselves, every other year, as a premier event focusing on Minimal Residual Cancer in patients with solid tumors.
The MONTPELLIER ISMRC meeting is a great opportunity to gather during three days, researchers from academia and industry to share information about the most recent technical developments, clinical trials and late breaking news.
The 2018 meeting in Montpellier is organized together with the established EU-IMI consortium CANCER-ID and brings together basic and clinical researchers from academia and companies.
The MONTPELLIER-ISMRC 2018 program will focus on LIQUID BIOPSY in a broader sense and will include presentations on Circulating Tumor Cells (CTCs) as well as circulating nucleic acids (DNA, miRNA) and exosomes, with emphasis on clinical studies as well as the biology of metastasis, including cancer stemness, dormancy, epithelial-mesenchymal transition and immunomodulation of tumor cells.
After great cities like Munich, Berlin, Oslo, San Francisco, Hamburg, Athens, Osaka & Paris, the next ISMRC will take place May 3-5, 2018 at the Corum in Montpellier, France. We hope that you will enjoy your time attending this 11th ISMRC meeting in MONTPELLIER and enjoy the opportunity to exchange information and establish long lasting collaborations with your colleagues.
Catherine Alix-Panabières (Montpellier, France)
Klaus Pantel (Hamburg, Allemagne)